Latest Articles
- Research ArticleCNS Antigen-Specific Neuroinflammation Attenuates Ischemic Stroke With Involvement of Polarized Myeloid CellsKirsten Guse, Nina Hagemann, Lisa Thiele, et al.June 08, 2022
- Research ArticleOfatumumab Modulates Inflammatory T Cell Responses and Migratory Potential in Patients With Multiple SclerosisMarina Rode von Essen, Rikke Holm Hansen, Camilla Højgaard, et al.June 07, 2022
- Research ArticleRetinal Hyperreflecting Foci Associate With Cortical Pathology in Multiple SclerosisMarta Pengo, Silvia Miante, Silvia Franciotta, et al.May 23, 2022
- Clinical/Scientific NoteβIV-Spectrin Autoantibodies in 2 Individuals With Neuropathy of Possible Paraneoplastic OriginA Case SeriesChristopher M. Bartley, Thomas T. Ngo, Bonny D. Alvarenga, et al.May 17, 2022
- Research ArticleTransitioning From S1P Receptor Modulators to B Cell–Depleting Therapies in Multiple SclerosisClinical, Radiographic, and Laboratory DataWilliam M. Rowles, Wan-Yu Hsu, Kira McPolin, et al.May 17, 2022
- Research ArticleClinicopathologic Profiles of Sporadic Late-Onset Nemaline MyopathyPractical Importance of Anti–α-Actinin ImmunostainingBing Zhao, Tingjun Dai, Dandan Zhao, et al.May 17, 2022
- Research ArticleInnate Immune Cell–Related Pathology in the Thalamus Signals a Risk for Disability Progression in Multiple SclerosisOlavi Misin, Markus Matilainen, Marjo Nylund, et al.May 17, 2022
- Research ArticlesRole of Chitinase 3–like 1 as a Biomarker in Multiple SclerosisA Systematic Review and Meta-analysisStefano Floro, Tiziana Carandini, Anna Margherita Pietroboni, et al.May 09, 2022
- Clinical/Scientific NoteLongitudinal T-Cell Responses After a Third SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis on Ocrelizumab or FingolimodVirginia Palomares Cabeza, Laura Y.L. Kummer, Luuk Wieske, et al.May 06, 2022
- Research ArticleNeurosarcoidosis of the Cauda EquinaClinical Course, Radiographic and Electrodiagnostic Findings, Response to Treatment, and OutcomesGabriela Alejandra Bou, Rocio Garcia-Santibanez, Alexander Jordan Castilho, et al.April 29, 2022
Pages
Advertisement